Google parent company shopping around shoes that track weight and falls

Amy Baxter | | Health Exec | Digital Transformation
sport-shoe-1470061_1920.jpg

Verily, the life sciences business of Google parent company Alphabet, has a new prototype for shoes enabled with sensors that can help track weight, falls and movement, according to CNBC.

Verily has reportedly been looking for partners to develop the shoes, showing a prototype in private meetings in the hopes of bringing them to market, three people familiar with the project told CNBC.

The project is the latest example of the arms race in digital health from major companies, such as Apple and Amazon. Verily’s Study Watch recently earned FDA clearance for its electrocardiogram (ECG) feature. The Alphabet subsidiary also raised $1 billion in an investment round at the start of the year.

See the full story below:

Alphabet’s Verily has been working on health-tracking shoes to measure movement…

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Generative AI isn’t changing everything for patients and providers—but it’s not leaving much unaffected, either
Antibiotics prescriptions: There’s a large-language model for that
4 important AMA insights into physician thinking on, behavior with healthcare AI
Global consortium: The future of AI in healthcare is dynamic—and demanding
Healthcare systems are proceeding apace with GenAI—and learning as they go
To prepare tomorrow’s doctors for evidence-based medicine, instruct today’s med students in dHealth and AI

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”